Evidence map›Paper›PMID 38481372›Full record

ArticleClinical and translational medicine2024

Engineering small-molecule analogues of altiratinib via CREB-regulated transcription co-activator 3-target screening for the development of potent and safe topical therapeutics against skin hyperpigmentary diseases.

Jeong Hyeon Lee, Hongchan An, HyeJi Kwon, Su-Jeong Lee, Young Hye Park, Ji Sun Hwang, Min Young Kim, Hayoung Hwang, Jeong Yoon Kim, Seung Jin Lee and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jeong Hyeon LeeDepartment of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Hongchan AnCollege of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, Pocheon, South Korea.
HyeJi KwonDepartment of Brain Science, Brain Korea 21 project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Su-Jeong LeeNew Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, South Korea.
Young Hye ParkNew Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, South Korea.
Ji Sun HwangNew Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, South Korea.
Min Young KimNew Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, South Korea.
Hayoung HwangNew Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, South Korea.
Jeong Yoon KimDepartment of Brain Science, Brain Korea 21 project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Seung Jin LeeDepartment of Brain Science, Brain Korea 21 project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Sung Eun ChangDepartment of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Youngsup SongDepartment of Brain Science, Brain Korea 21 project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.ORCID 0000-0002-6268-5223

Funding

Ministry of Health & Welfare, Republic of Korea HP23C0072National Research Foundation of Korea 2020R1A4A4079708National Research Foundation of Korea RS-2023-00208426National Research Foundation of Korea RS-2023-00246165
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiogenesis InhibitorsAngiogenesis Inhibitors

Identifiers

PMID38481372
PMCPMC10938064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.